Cytokine production by infrapatellar fat pad can be stimulated by interleukin 1β and inhibited by peroxisome proliferator activated receptor α agonist

Annals of the Rheumatic Diseases

Volumn 71, Issue 6, 2012, Pages 1012-1018

  Clockaerts, Stefan ^a,b   Bastiaansen Jenniskens, Yvonne M ^b   Feijt, Carola ^b   De Clerck, Luc ^a   Verhaar, J A N ^b   Zuurmond, Anne Marie ^c   Stojanovic Susulic, Vedrana ^d   Somville, Johan ^a   Kloppenburg, Margreet ^e   Van Osch, Gerjo J V M ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c TNO   (Netherlands)

^d JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PIRINIXIC ACID; PROSTAGLANDIN E2; PROSTAGLANDIN ENDOPEROXIDE SYNTHASE 2; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG MECHANISM; DRUG POTENTIATION; EXPLANT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; INFRAPATELLAR FAT PAD; OSTEOARTHRITIS; PATELLA; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN SYNTHESIS REGULATION; SYNOVIUM; TISSUE DISTRIBUTION;

ADIPOSE TISSUE; AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; CHEMOKINE CCL2; CYCLOOXYGENASE 2; CYTOKINES; DINOPROSTONE; GENE EXPRESSION; HUMANS; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; LEPTIN; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PATELLA; PPAR ALPHA; PYRIMIDINES; TISSUE CULTURE TECHNIQUES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84860919318     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200688     Document Type: Article

References (31)

1. Bondeson J, Wainwright SD, Lauder S, et al. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and infl ammatory responses in osteoarthritis. Arthritis Res Ther 2006;8:R187.
2. Hunter DJ, Felson DT. Osteoarthritis. BMJ 2006;332:639-42.
3. Bastiaansen-Jenniskens YM, Clockaerts S, Feijt C, et al. Infrapatellar fat pad of patients with end-stage osteoarthritis inhibits catabolic mediators in cartilage. Ann Rheum Dis 2012;71:288-94.
4. Clockaerts S, Bastiaansen-Jenniskens YM, Runhaar J, et al. The infrapatellar fat pad should be considered as an active osteoarthritic joint tissue: a narrative review. Osteoarthr Cartil 2010;18:876-82.
5. Klein-Wieringa IR, Kloppenburg M, Bastiaansen-Jenniskens YM, et al. The infrapatellar fat pad of patients with osteoarthritis has an infl ammatory phenotype. Ann Rheum Dis 2011;70:851-7.
6. Distel E, Cadoudal T, Durant S, et al. The infrapatellar fat pad in knee osteoarthritis: an important source of interleukin-6 and its soluble receptor. Arthritis Rheum 2009;60:3374-7.
7. Presle N, Pottie P, Dumond H, et al. Differential distribution of adipokines between serum and synovial fl uid in patients with osteoarthritis. Contribution of joint tissues to their articular production. Osteoarthr Cartil 2006;14:690-5. (Pubitemid 43842733)
8. Ushiyama T, Chano T, Inoue K, et al. Cytokine production in the infrapatellar fat pad: another source of cytokines in knee synovial fl uids. Ann Rheum Dis 2003;62:108-12. (Pubitemid 36135384)
9. Clockaerts S, Bastiaansen-Jenniskens YM, Feijt C, et al. Peroxisome proliferator activated receptor alpha activation decreases infl ammatory and destructive responses in osteoarthritic cartilage. Osteoarthr Cartil 2011;19:895-902.
10. François M, Richette P, Tsagris L, et al. Activation of the peroxisome proliferator-activated receptor alpha pathway potentiates interleukin-1 receptor antagonist production in cytokine-treated chondrocytes. Arthritis Rheum 2006;54:1233-45. (Pubitemid 43672935)
11. Delerive P, De Bosscher K, Besnard S, et al. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular infl ammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem 1999;274:32048-54.
12. Okamoto H, Iwamoto T, Kotake S, et al. Inhibition of NF-kappaB signaling by fenofi brate, a peroxisome proliferator-activated receptor-alpha ligand, presents a therapeutic strategy for rheumatoid arthritis. Clin Exp Rheumatol 2005;23:323-30. (Pubitemid 40823539)
13. Crisafulli C, Cuzzocrea S. The role endogenous and exogenous ligands for the peroxisome proliferator-activated receptor alpha (PPAR-alpha) in the regulation of infl ammation in macrophages. Shock 2008 Oct 23 [Epub ahead of print].
14. Okamoto HP, Iwamoto TP, Kotake SP, et al. Inhibition of NF-κB signaling by fenofi brate, a peroxisome proliferator-activated receptor-alpha ligand, presents a therapeutic strategy for rheumatoid arthritis. Clin Exp Rheumatol 2005;23(Suppl 3):323-330.
15. Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol 2007;213:626-34.
16. Westacott CI, Whicher JT, Barnes IC, et al. Synovial fl uid concentration of fi ve different cytokines in rheumatic diseases. Ann Rheum Dis 1990;49:676-81. (Pubitemid 20279117)
17. Fain JN. Release of interleukins and other infl ammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm 2006;74:443-77.
18. Goldring SR, Goldring MB. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res 2004;(Suppl 427):S27-36. (Pubitemid 39362798)
19. Gomez R, Lago F, Gomez-Reino J, et al. Adipokines in the skeleton: infl uence on cartilage function and joint degenerative diseases. J Mol Endocrinol 2009;43:11-8.
20. Schulze-Tanzil G, Zreiqat H, Sabat R, et al. Interleukin-10 and articular cartilage: experimental therapeutical approaches in cartilage disorders. Curr Gene Ther 2009;9:306-15.
21. Poleni PEP, Bianchi AP, Etienne SP, et al. Agonists of peroxisome proliferators-activated receptors (PPAR) alpha, beta/delta or gamma reduce transforming growth factor (TGF)-beta-induced proteoglycans production in chondrocytes. Osteoarthr Cartil 2007;15(Suppl 5):493-505.
22. Bastiaansen-Jenniskens YM, Clockaerts S. Infrapatellar fat pad of late osteoarthritis patients induces an anti-catabolic response in cartilage. Los Angeles, California, USA: Orthopaedic Research Society, 2011.
23. Reijman M, Pols HA, Bergink AP, et al. Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: the Rotterdam Study. Ann Rheum Dis 2007;66:158-62. (Pubitemid 46226047)
24. Bordji K, Grillasca JP, Gouze JN, et al. Evidence for the presence of peroxisome proliferator-activated receptor (PPAR) alpha and gamma and retinoid Z receptor in cartilage. PPARgamma activation modulates the effects of interleukin-1beta on rat chondrocytes. J Biol Chem 2000;275:12243-50. (Pubitemid 30237804)
25. Stienstra R, Joosten LA, Koenen T, et al. The infl ammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab 2010;12:593-605.
26. Farahat MN, Yanni G, Poston R, et al. Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1993;52:870-5. (Pubitemid 24019143)
27. Conaghan PG, Vanharanta H, Dieppe PA. Is progressive osteoarthritis an atheromatous vascular disease? Ann Rheum Dis 2005;64:1539-41. (Pubitemid 41532034)
28. Davies-Tuck ML, Hanna F, Davis SR, et al. Total cholesterol and triglycerides are associated with the development of new bone marrow lesions in asymptomatic middle-aged women - a prospective cohort study. Arthritis Res Ther 2009;11:R181.
29. Clockaerts S, Bierma-Zeinstra SM. Comment on: Statins and the joint: multiple target for a global protection? Semin Arthritis Rheum 2011;40:588.
30. Alagona P Jr. Fenofi bric acid: a new fi brate approved for use in combination with statin for the treatment of mixed dyslipidemia. Vasc Health Risk Manag 2010;6:351-62.
31. Remick J, Weintraub H, Setton R, et al. Fibrate therapy: an update. Cardiol Rev 2008;16:129-41. (Pubitemid 351549675)